We've put some small files called cookies on your device to make our site work.
We'd also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.
Let us know if this is OK. We'll use a cookie to save your choice. You can read more about our cookies before you choose.
Rituximab for the treatment of primary Sjogren’s syndrome (PSS) in adults
NHS England will not routinely commission rituximab for the treatment of primary Sjogren’s syndrome in adults in accordance with the criteria outlined in this document.
